This company listing is no longer active
Solgenics Balance Sheet Health
Financial Health criteria checks 1/6
Solgenics has a total shareholder equity of $13.0M and total debt of $5.7M, which brings its debt-to-equity ratio to 44.1%. Its total assets and total liabilities are $19.0M and $6.0M respectively.
Key information
44.1%
Debt to equity ratio
US$5.73m
Debt
Interest coverage ratio | n/a |
Cash | US$436.00k |
Equity | US$12.99m |
Total liabilities | US$6.04m |
Total assets | US$19.03m |
Financial Position Analysis
Short Term Liabilities: SGN's short term assets ($510.0K) do not cover its short term liabilities ($6.0M).
Long Term Liabilities: SGN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SGN's net debt to equity ratio (40.8%) is considered high.
Reducing Debt: SGN's debt to equity ratio has increased from 17.9% to 44.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if SGN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.